Trials / Conditions / Unresectable Gastric Adenocarcinoma

Unresectable Gastric Adenocarcinoma

6 registered clinical trials studyying Unresectable Gastric Adenocarcinoma — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial NCT06203600	National Cancer Institute (NCI)	Phase 2 / Phase 3
Recruiting	A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People Wit NCT06251973	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastati NCT05677490	Alliance for Clinical Trials in Oncology	Phase 3
Recruiting	Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli NCT05269381	Mayo Clinic	Phase 1 / Phase 2
Recruiting	Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno NCT05041153	M.D. Anderson Cancer Center	EARLY_Phase 1
Active Not Recruiting	Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gast NCT03641313	National Cancer Institute (NCI)	Phase 2